Bellerophon provides clinical program update and reports second quarter 2020 financial results

Bellerophon provides clinical program update and reports second quarter 2020 financial results.q2 loss per share $0.51.q2 earnings per share estimate $-0.72 -- refinitiv ibes data.company expects to initiate rebuild study in second half of 2020.as of june 30, 2020, company had cash and cash equivalents of $59.3 million.

BLPH Ratings Summary

BLPH Quant Ranking